INTERACTIONS OF RANKL, OSTEOPROTEGERIN AND ADIPOKINES IN REGULATION OF BONE REMODELING IN EXPERIMENTAL CHRONIC KIDNEY...

Area of Science:

• Endocrinology
• Nephrology
• Bone Biology

Background:

• The RANK-RANKL-osteoprotegerin axis is crucial for bone remodeling and bone-kidney interrelations.
• Adipokines like adiponectin and visfatin are increasingly recognized as regulators in these pathways.
• Understanding their interplay is vital, especially in conditions like chronic kidney disorder (CKD).

Purpose of the Study:

• To investigate the roles of the RANK-RANKL-osteoprotegerin axis and the adipokines adiponectin and visfatin in a rat model of CKD.
• To explore the interrelationships between these key cytokines in the context of CKD.
• To elucidate the specific effects of these cytokines on bone-kidney interactions during renal impairment.

Main Methods:

• A chronic kidney disorder model was established in rats 12 weeks post-acute kidney injury induction via glycerol injection.
• Serum levels of Receptor Activator of Nuclear factor Kappa-B Ligand (RANKL), osteoprotegerin (OPG), adiponectin, and visfatin were quantified using Enzyme-Linked Immunosorbent Assay (ELISA).

Main Results:

• Rats with CKD exhibited significant increases in RANKL, osteoprotegerin, adiponectin, and visfatin levels.
• Altered interrelationships among these cytokines were observed in the CKD model.
• The study identified changes in the cytokine network regulating bone-kidney axis in response to renal dysfunction.

Conclusions:

• The RANKL-triggered cytokine axis in the bone-kidney network demonstrates an inflammatory character in CKD.
• Visfatin also contributes to the inflammatory response in this model.
• Adiponectin appears to exert a protective, bone-preserving effect, counteracting the inflammatory influences.